• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Living Cell Technologies Limited (LCT) - Articles and news items


NTCELL Phase I/IIa study meets endpoints

Industry news / 15 June 2015 / Victoria White

A Phase I/IIa study of NTCELL, an regenerative cell therapy being studied as a disease-modifying agent in Parkinson’s disease, has met its endpoints…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +